Did You Know the FDA Required Changes to Actos Packaging?

Actos (pioglitazone) is a dangerous drug, although too many patients and physicians don’t realize it. In fact, because of the medical risks associated with Actos, the Food and Drug Administration (FDA) has issued repeated warnings about pioglitazone treatments since 2007. Those warnings have addressed both the risk of heart failure and, more recently, the dramatic risk of bladder cancer associated with Actos.


How serious are these risks? On repeated occasions, the FDA has required the makers of pioglitazone-based medications, including Actos, to modify the drug’s labels and packaging in an effort to better educate and notify consumers, patients, and doctors.


Surprised to learn that the FDA would require modifications of Actos packaging? You’re not alone. Thousands of consumers have been surprised to learn that the makers of Actos systematically failed to appropriately test and market this dangerous drug. If you’ve been taking Actos and think that you’ve suffered as a result, you should contact the dangerous drug attorneys at Fears Nachawati immediately. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for you!

Trackbacks (0) Links to blogs that reference this article Trackback URL
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.

Remember personal info?